Research ArticleTheranostics
Open Access
Diagnostic Accuracy of 18F-PSMA-1007 PET/CT Imaging for Lymph Node Staging of Prostate Carcinoma in Primary and Biochemical Recurrence
Katharina Sprute, Vasko Kramer, Stefan A. Koerber, Manuel Meneses, Rene Fernandez, Cristian Soza-Ried, Mathias Eiber, Wolfgang A. Weber, Isabel Rauscher, Kambiz Rahbar, Michael Schaefers, Tadashi Watabe, Motohide Uemura, Sadahiro Naka, Norio Nonomura, Jun Hatazawa, Constantin Schwab, Viktoria Schütz, Markus Hohenfellner, Tim Holland-Letz, Juergen Debus, Clemens Kratochwil, Horacio Amaral, Pete L. Choyke, Uwe Haberkorn, Camilo Sandoval and Frederik L. Giesel
Journal of Nuclear Medicine February 2021, 62 (2) 208-213; DOI: https://doi.org/10.2967/jnumed.120.246363
Katharina Sprute
1Department of Nuclear Medicine, University Hospital, Heidelberg, Germany
Vasko Kramer
2Positronpharma SA, Santiago, Chile
3Center of Nuclear Medicine, PositronMed, Santiago, Chile
Stefan A. Koerber
4Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany
5National Center for Tumor Disease, Heidelberg, Germany
6Heidelberg Institute of Radiation Oncology, Heidelberg, Germany
Manuel Meneses
7Fundación Arturo Lopez Perez, Santiago, Chile
Rene Fernandez
3Center of Nuclear Medicine, PositronMed, Santiago, Chile
Cristian Soza-Ried
3Center of Nuclear Medicine, PositronMed, Santiago, Chile
Mathias Eiber
8Department of Nuclear Medicine, Munich University Hospital, Munich, Germany
Wolfgang A. Weber
8Department of Nuclear Medicine, Munich University Hospital, Munich, Germany
Isabel Rauscher
8Department of Nuclear Medicine, Munich University Hospital, Munich, Germany
Kambiz Rahbar
9Department of Nuclear Medicine, Muenster University Hospital, Muenster, Germany
Michael Schaefers
9Department of Nuclear Medicine, Muenster University Hospital, Muenster, Germany
Tadashi Watabe
10Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, Osaka, Japan
Motohide Uemura
11Department of Urology, Osaka University Graduate School of Medicine, Osaka, Japan
Sadahiro Naka
12Osaka University Hospital, Osaka, Japan
Norio Nonomura
11Department of Urology, Osaka University Graduate School of Medicine, Osaka, Japan
Jun Hatazawa
13Research Center for Nuclear Physics, Osaka University, Osaka, Japan
Constantin Schwab
14Department of Pathology, Heidelberg University Hospital, Heidelberg, Germany
Viktoria Schütz
15Department of Urology, Heidelberg University Hospital, Heidelberg, Germany
Markus Hohenfellner
15Department of Urology, Heidelberg University Hospital, Heidelberg, Germany
Tim Holland-Letz
16Department of Biostatistics, German Cancer Research Center, Heidelberg, Germany
Juergen Debus
4Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany
5National Center for Tumor Disease, Heidelberg, Germany
6Heidelberg Institute of Radiation Oncology, Heidelberg, Germany
6Heidelberg Institute of Radiation Oncology, Heidelberg, Germany
18Department of Radiation Oncology, Heidelberg Ion-Beam Therapy Center, Heidelberg University Hospital, Heidelberg, Germany
19Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center, Heidelberg, Germany
Clemens Kratochwil
1Department of Nuclear Medicine, University Hospital, Heidelberg, Germany
20Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany; and
Horacio Amaral
2Positronpharma SA, Santiago, Chile
3Center of Nuclear Medicine, PositronMed, Santiago, Chile
Pete L. Choyke
21Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Uwe Haberkorn
1Department of Nuclear Medicine, University Hospital, Heidelberg, Germany
20Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany; and
Camilo Sandoval
7Fundación Arturo Lopez Perez, Santiago, Chile
Frederik L. Giesel
1Department of Nuclear Medicine, University Hospital, Heidelberg, Germany
10Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, Osaka, Japan
17German Cancer Consortium, Heidelberg, Germany
20Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany; and
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 62, Issue 2
February 1, 2021
Diagnostic Accuracy of 18F-PSMA-1007 PET/CT Imaging for Lymph Node Staging of Prostate Carcinoma in Primary and Biochemical Recurrence
Katharina Sprute, Vasko Kramer, Stefan A. Koerber, Manuel Meneses, Rene Fernandez, Cristian Soza-Ried, Mathias Eiber, Wolfgang A. Weber, Isabel Rauscher, Kambiz Rahbar, Michael Schaefers, Tadashi Watabe, Motohide Uemura, Sadahiro Naka, Norio Nonomura, Jun Hatazawa, Constantin Schwab, Viktoria Schütz, Markus Hohenfellner, Tim Holland-Letz, Juergen Debus, Clemens Kratochwil, Horacio Amaral, Pete L. Choyke, Uwe Haberkorn, Camilo Sandoval, Frederik L. Giesel
Journal of Nuclear Medicine Feb 2021, 62 (2) 208-213; DOI: 10.2967/jnumed.120.246363
Diagnostic Accuracy of 18F-PSMA-1007 PET/CT Imaging for Lymph Node Staging of Prostate Carcinoma in Primary and Biochemical Recurrence
Katharina Sprute, Vasko Kramer, Stefan A. Koerber, Manuel Meneses, Rene Fernandez, Cristian Soza-Ried, Mathias Eiber, Wolfgang A. Weber, Isabel Rauscher, Kambiz Rahbar, Michael Schaefers, Tadashi Watabe, Motohide Uemura, Sadahiro Naka, Norio Nonomura, Jun Hatazawa, Constantin Schwab, Viktoria Schütz, Markus Hohenfellner, Tim Holland-Letz, Juergen Debus, Clemens Kratochwil, Horacio Amaral, Pete L. Choyke, Uwe Haberkorn, Camilo Sandoval, Frederik L. Giesel
Journal of Nuclear Medicine Feb 2021, 62 (2) 208-213; DOI: 10.2967/jnumed.120.246363
Jump to section
Related Articles
Cited By...
- The Diagnostic Value of the Sentinel Node Procedure to Detect Occult Lymph Node Metastases in PSMA PET/CT Node-Negative Prostate Cancer Patients
- Phase III Study of 18F-PSMA-1007 Versus 18F-Fluorocholine PET/CT for Localization of Prostate Cancer Biochemical Recurrence: A Prospective, Randomized, Crossover Multicenter Study
- Should 68Ga-PSMA PET/CT Replace CT and Bone Scan in Clinical Staging of High-risk Prostate Cancer?
- The Added Value of 18F-FDG PET/CT Compared with 68Ga-PSMA PET/CT in Patients with Castration-Resistant Prostate Cancer